Glodraph t1_j9jxtli wrote

Showing provable results is way more difficult than it seems and these new info is only to attract investors and money. It's way more difficult than altering a buch of genes (which we still can't do in a super secure, efficient and safe way) and call it a day. Most of aging also comes from food, exercise, pollution etc..good luck removing microplastics and pfas from the body even if you're a billionaire.


Glodraph t1_izp57lg wrote

Yep. Main issue is synthesis, cost, delivery, elimination rates and see if there is a therapeutic interval that make these molecules a viable treatment over the citotoxic effect. Plus you ideally want a lot of testing, from vitro to vivo. There is a lot to work on, but this could be an useful way to design molecules in a way faster way, then slim down to the most promising ones to test.


Glodraph t1_it3bgdp wrote

Or they could just...change materials? IBM already build a graphene transistor. I think they could find way better materials to use which could bring higher performance with better efficiency.


Glodraph t1_irfkos0 wrote

Yeah np lol. I cannot stress enough that it's my personal opinion. I am a student so my knowledge and qualification is limited and estimates on treatments and such are always a bet. But I think we're taking the right steps with technlogies like genetic editing and mRNA vaccines (which are already being tested for HIV). The issue is that the virus, even if it comes in 2 main variants HIV-1 and HIV-2, shows a huge genetic variability even in the same patience; it's like having 10.000 covid variants in one person. This make targeting and treatment very difficult as you need either a "universal" target or a system that can evolve and adapt with the virus. Now you can see why it's extremely difficult to eradicate. Huge steps were made though so I am optimistic about this.